| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.29 | 1e-15 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.29 | 4e-15 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.26 | 9e-14 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.26 | 4e-13 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.24 | 2e-12 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.24 | 3e-11 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.23 | 7e-11 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.25 | 1e-10 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.22 | 6e-10 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.2 | 8e-10 |